Cubist Systematic Strategies’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,698
| Closed | -$103K | – | 2751 |
|
|
2023
Q3 | $103K | Sell |
1,698
-3,430
| -67% | -$207K | ﹤0.01% | 1631 |
|
|
2023
Q2 | $522K | Buy |
+5,128
| New | +$522K | ﹤0.01% | 1395 |
|
|
2022
Q3 | – | Sell |
-7,719
| Closed | -$2.54M | – | 3950 |
|
|
2022
Q2 | $2.54M | Buy |
7,719
+7,635
| +9,089% | +$2.51M | 0.02% | 1375 |
|
|
2022
Q1 | $37K | Sell |
84
-2,946
| -97% | -$1.3M | ﹤0.01% | 3397 |
|
|
2021
Q4 | $1.33M | Buy |
3,030
+2,509
| +482% | +$1.1M | 0.01% | 1693 |
|
|
2021
Q3 | $290K | Buy |
+521
| New | +$290K | ﹤0.01% | 2378 |
|
|
2021
Q2 | – | Sell |
-1,559
| Closed | -$1.22M | – | 3140 |
|
|
2021
Q1 | $1.22M | Buy |
1,559
+422
| +37% | +$330K | 0.02% | 1402 |
|
|
2020
Q4 | $619K | Sell |
1,137
-786
| -41% | -$428K | 0.01% | 1664 |
|
|
2020
Q3 | $881K | Buy |
1,923
+559
| +41% | +$256K | 0.01% | 1407 |
|
|
2020
Q2 | $840K | Buy |
1,364
+1,078
| +377% | +$664K | 0.01% | 1286 |
|
|
2020
Q1 | $136K | Sell |
286
-1,332
| -82% | -$633K | ﹤0.01% | 1836 |
|
|
2019
Q4 | $938K | Buy |
1,618
+1,265
| +358% | +$733K | 0.02% | 1199 |
|
|
2019
Q3 | $232K | Buy |
+353
| New | +$232K | ﹤0.01% | 1698 |
|
|
2019
Q2 | – | Sell |
-58
| Closed | -$41K | – | 2608 |
|
|
2019
Q1 | $41K | Sell |
58
-1,054
| -95% | -$745K | ﹤0.01% | 2133 |
|
|
2018
Q4 | $521K | Buy |
+1,112
| New | +$521K | 0.02% | 939 |
|
|
2017
Q1 | – | Sell |
-55
| Closed | -$19K | – | 1901 |
|
|
2016
Q4 | $19K | Buy |
55
+47
| +588% | +$16.2K | ﹤0.01% | 1637 |
|
|
2016
Q3 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 1667 |
|
|
2016
Q1 | – | Sell |
-46
| Closed | -$28K | – | 1872 |
|
|
2015
Q4 | $28K | Sell |
46
-393
| -90% | -$239K | ﹤0.01% | 1662 |
|
|
2015
Q3 | $226K | Buy |
+439
| New | +$226K | 0.01% | 1401 |
|